SETON HALL UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1856-01-01
- Employees
- 860
- Market Cap
- -
- Website
- http://www.shu.edu
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer to Spearhead Avexitide Launch
• Amylyx Pharmaceuticals has appointed Dan Monahan as Chief Commercial Officer to lead the commercialization of their product portfolio.
• Monahan will focus on the potential approval and launch of avexitide, a GLP-1 receptor antagonist for post-bariatric hypoglycemia (PBH).
• Amylyx plans to initiate the Phase 3 LUCIDITY trial of avexitide in Q1 2025, with data expected in 2026, to address the unmet need for PBH treatment.
• Monahan brings over 20 years of experience in the biopharmaceutical industry, including successful launches at Otsuka, Novartis, and Sanofi.
© Copyright 2025. All Rights Reserved by MedPath